Multivariate analysis for determinants of complication rate
Complication/parameter . | RR . | 95% CI . | P . |
---|---|---|---|
EMH | |||
Age > 35 y | 0.85 | 0.46-1.58 | .610 |
Ferritin ≥ 1000 μg/L | 0.85 | 0.51-1.44 | .548 |
Splenectomy | 0.44 | 0.26-0.73 | .001* |
Transfusion | 0.06 | 0.03-0.09 | < .001* |
Hydroxyurea | 0.52 | 0.30-0.91 | .022* |
PHT | |||
Age > 35 y | 2.59 | 1.08-6.19 | .032* |
Splenectomy | 4.11 | 1.99-8.47 | < .001* |
Transfusion | 0.33 | 0.18-0.58 | < .001* |
Hydroxyurea | 0.42 | 0.20-0.90 | .025* |
Iron chelation | 0.53 | 0.29-0.95 | .032* |
HF | |||
Splenectomy | 2.88 | 0.99-8.32 | .051 |
Transfusion | 0.06 | 0.02-0.17 | < .001* |
Hydroxyurea | 1.84 | 0.98-3.47 | .057 |
Iron chelation | 0.45 | 0.18-1.12 | .086 |
Thrombosis | |||
Age > 35 y | 2.60 | 1.39-4.87 | .003* |
Female | 1.27 | 0.74-2.19 | .387 |
Hb ≥ 90 g/L | 0.41 | 0.23-0.71 | .001* |
Ferritin ≥ 1000 μg/L | 1.86 | 1.09-3.16 | .023* |
Splenectomy | 6.59 | 3.09-14.05 | < .001* |
Transfusion | 0.28 | 0.16-0.48 | < .001* |
Hydroxyurea | 0.56 | 0.28-1.10 | .090 |
Iron chelation | 0.97 | 0.56-1.68 | .912 |
Cholelithiasis | |||
Age > 35 y | 2.76 | 1.56-4.87 | < .001* |
Female | 1.96 | 1.18-3.25 | .010* |
Splenectomy | 5.19 | 2.72-9.90 | < .001* |
Transfusion | 0.36 | 0.21-0.62 | < .001* |
Hydroxyurea | 0.55 | 0.29-1.02 | .058 |
Iron chelation | 0.30 | 0.18-0.51 | < .001* |
Abnormal liver function | |||
Ferritin ≥ 1000 μg/L | 1.74 | 1.00-3.02 | .049* |
Transfusion | 1.56 | 0.76-3.17 | .224 |
Leg ulcers | |||
Age > 35 y | 2.09 | 1.05-4.16 | .036* |
Ferritin ≥ 1000 μg/L | 1.29 | 0.67-2.47 | .449 |
Splenectomy | 3.98 | 1.68-9.39 | .002* |
Transfusion | 0.39 | 0.20-0.76 | .006* |
Hydroxyurea | 0.10 | 0.02-0.43 | .002* |
Iron chelation | 0.68 | 0.35-1.34 | .269 |
DM | |||
Age > 35 y | 2.00 | 0.53-7.62 | .309 |
Splenectomy | 5.79 | 0.71-47.21 | .101 |
Hydroxyurea | 0.24 | 0.03-2.20 | .208 |
Iron chelation | 0.40 | 0.10-1.62 | .197 |
Hypothyroidism | |||
Age > 35 y | 1.01 | 0.46-2.23 | .984 |
Splenectomy | 6.04 | 2.03-17.92 | .001* |
Transfusion | 13.3 | 1.78-100.00 | .012 |
Hydroxyurea | 0.05 | 0.01-0.45 | .003* |
Iron chelation | 0.49 | 0.22-1.07 | .073 |
Osteoporosis | |||
Age > 35 y | 3.51 | 2.06-5.99 | < .001* |
Female | 1.97 | 1.19-3.27 | .009* |
Ferritin ≥ 1000 μg/L | 1.60 | 0.96-2.68 | .072 |
Splenectomy | 4.73 | 2.72-8.24 | < .001* |
Transfusion | 3.10 | 1.64-5.85 | < .001* |
Hydroxyurea | 0.02 | 0.01-0.09 | < .001* |
Iron chelation | 0.40 | 0.24-0.68 | .001* |
Hypogonadism | |||
Age > 35 y | 1.05 | 0.51-2.15 | .900 |
Female | 2.98 | 1.79-4.96 | < .001* |
Ferritin ≥ 1000 μg/L | 2.63 | 1.59-4.36 | < .001* |
Splenectomy | 1.65 | 0.97-2.77 | .056 |
Transfusion | 16.13 | 4.85-52.63 | < .001* |
Hydroxyurea | 4.32 | 2.49-7.49 | < .001* |
Iron chelation | 2.51 | 1.48-4.26 | .001* |
Complication/parameter . | RR . | 95% CI . | P . |
---|---|---|---|
EMH | |||
Age > 35 y | 0.85 | 0.46-1.58 | .610 |
Ferritin ≥ 1000 μg/L | 0.85 | 0.51-1.44 | .548 |
Splenectomy | 0.44 | 0.26-0.73 | .001* |
Transfusion | 0.06 | 0.03-0.09 | < .001* |
Hydroxyurea | 0.52 | 0.30-0.91 | .022* |
PHT | |||
Age > 35 y | 2.59 | 1.08-6.19 | .032* |
Splenectomy | 4.11 | 1.99-8.47 | < .001* |
Transfusion | 0.33 | 0.18-0.58 | < .001* |
Hydroxyurea | 0.42 | 0.20-0.90 | .025* |
Iron chelation | 0.53 | 0.29-0.95 | .032* |
HF | |||
Splenectomy | 2.88 | 0.99-8.32 | .051 |
Transfusion | 0.06 | 0.02-0.17 | < .001* |
Hydroxyurea | 1.84 | 0.98-3.47 | .057 |
Iron chelation | 0.45 | 0.18-1.12 | .086 |
Thrombosis | |||
Age > 35 y | 2.60 | 1.39-4.87 | .003* |
Female | 1.27 | 0.74-2.19 | .387 |
Hb ≥ 90 g/L | 0.41 | 0.23-0.71 | .001* |
Ferritin ≥ 1000 μg/L | 1.86 | 1.09-3.16 | .023* |
Splenectomy | 6.59 | 3.09-14.05 | < .001* |
Transfusion | 0.28 | 0.16-0.48 | < .001* |
Hydroxyurea | 0.56 | 0.28-1.10 | .090 |
Iron chelation | 0.97 | 0.56-1.68 | .912 |
Cholelithiasis | |||
Age > 35 y | 2.76 | 1.56-4.87 | < .001* |
Female | 1.96 | 1.18-3.25 | .010* |
Splenectomy | 5.19 | 2.72-9.90 | < .001* |
Transfusion | 0.36 | 0.21-0.62 | < .001* |
Hydroxyurea | 0.55 | 0.29-1.02 | .058 |
Iron chelation | 0.30 | 0.18-0.51 | < .001* |
Abnormal liver function | |||
Ferritin ≥ 1000 μg/L | 1.74 | 1.00-3.02 | .049* |
Transfusion | 1.56 | 0.76-3.17 | .224 |
Leg ulcers | |||
Age > 35 y | 2.09 | 1.05-4.16 | .036* |
Ferritin ≥ 1000 μg/L | 1.29 | 0.67-2.47 | .449 |
Splenectomy | 3.98 | 1.68-9.39 | .002* |
Transfusion | 0.39 | 0.20-0.76 | .006* |
Hydroxyurea | 0.10 | 0.02-0.43 | .002* |
Iron chelation | 0.68 | 0.35-1.34 | .269 |
DM | |||
Age > 35 y | 2.00 | 0.53-7.62 | .309 |
Splenectomy | 5.79 | 0.71-47.21 | .101 |
Hydroxyurea | 0.24 | 0.03-2.20 | .208 |
Iron chelation | 0.40 | 0.10-1.62 | .197 |
Hypothyroidism | |||
Age > 35 y | 1.01 | 0.46-2.23 | .984 |
Splenectomy | 6.04 | 2.03-17.92 | .001* |
Transfusion | 13.3 | 1.78-100.00 | .012 |
Hydroxyurea | 0.05 | 0.01-0.45 | .003* |
Iron chelation | 0.49 | 0.22-1.07 | .073 |
Osteoporosis | |||
Age > 35 y | 3.51 | 2.06-5.99 | < .001* |
Female | 1.97 | 1.19-3.27 | .009* |
Ferritin ≥ 1000 μg/L | 1.60 | 0.96-2.68 | .072 |
Splenectomy | 4.73 | 2.72-8.24 | < .001* |
Transfusion | 3.10 | 1.64-5.85 | < .001* |
Hydroxyurea | 0.02 | 0.01-0.09 | < .001* |
Iron chelation | 0.40 | 0.24-0.68 | .001* |
Hypogonadism | |||
Age > 35 y | 1.05 | 0.51-2.15 | .900 |
Female | 2.98 | 1.79-4.96 | < .001* |
Ferritin ≥ 1000 μg/L | 2.63 | 1.59-4.36 | < .001* |
Splenectomy | 1.65 | 0.97-2.77 | .056 |
Transfusion | 16.13 | 4.85-52.63 | < .001* |
Hydroxyurea | 4.32 | 2.49-7.49 | < .001* |
Iron chelation | 2.51 | 1.48-4.26 | .001* |
RR indicates adjusted relative risk; CI, confidence interval; and DM, diabetes mellitus.
Statistically significant.